Regional research offices
Chuck Howard - Patient story
Julie Randall - Patient story
Tara Foote - Provider story
If you have questions about clinical trials or want help finding the right one for you, contact our:
Patient Engagement Center Phone: 844-552-2734
This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.
Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.
Histologically-proven metastatic or locally-advanced relapsed/refractory HER2+ breast cancer based on the most recently...
Key Inclusion Criteria:
•Male or female, ≥ 18 to ≤ 85 years
•History of chronic HF (defined as requiring treatment for HF for a minimum of 30 days...
This study will employ a phase Ib design using the established dose of CAVATAK with pembrolizumab in subjects with advanced melanoma for whom...
The majority of melanoma vaccines tested to date have been antigen-specific vaccines targeting melanoma-specific or associated antigens and...
This is a 5-part dose-finding and preliminary efficacy study of pembrolizumab (Pembro) + dabrafenib (D) + trametinib (T) for participants with...